Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean

Cancer Causes and Control

Volumn 24, Issue 11, 2013, Pages 1963-1972

  Eom, Sang Yong ^a   Yim, Dong Hyuk ^a   Zhang, Yanwei ^a   Yun, Jung Kuk ^a   Moon, Sun In ^a   Yun, Hyo Yung ^a   Song, Young Jin ^a   Youn, Sei Jin ^a   Hyun, Taisun ^b   Park, Joo Seung ^c   Kim, Byung Sik ^d   Lee, Jong Young ^e   Kim, Yong Dae ^a   Kim, Heon ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

^c Eulji University   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Korea National Institute of Health   (South Korea)

Author keywords

Aflatoxin B1; Cytochrome P450 1A2; Epoxide hydrolase; Gastric cancer; Genetic polymorphism; Glutathione S transferase

Indexed keywords

AFLATOXIN B1; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; CANCER PATIENT; CANCER RISK; CHEMICAL INTERACTION; CONTROLLED STUDY; CYP1A2 GENE; CYP2E1 GENE; DIETARY INTAKE; DNA POLYMORPHISM; EPHX1 GENE; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; INTERVIEW; KOREAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER; STOMACH CARCINOGENESIS; STRUCTURED QUESTIONNAIRE;

AFLATOXIN B1; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; EPOXIDE HYDROLASES; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POISONS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84886793529     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0272-3     Document Type: Article

References (51)

1. The Korea Central Cancer Registry, National Cancer Center (2011) Annual report of cancer statistics in Korea in 2009. Ministry of Health and Welfare, Seoul
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
3. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY (2002) Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97:531-535
4. Tsugane S, Sasazuki S (2007) Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10:75-83
5. Lee JK, Park BJ, Yoo KY, Ahn YO (1995) Dietary factors and stomach cancer: a case-control study in Korea. Int J Epidemiol 24:33-41
6. Kim HJ, Lee SS, Choi BY, Kim MK (2007) Nitrate intake relative to antioxidant vitamin intake affects gastric cancer risk: a case-control study in Korea. Nutr Cancer 59:185-191
7. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, Roe IH, Seo JK, Sim JG, Ahn H, Yoon BC, Lee SW et al (2001) Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 16:969-975
8. Nan HM, Park JW, Song YJ, Yun HY, Park JS, Hyun T, Youn SJ, Kim YD, Kang JW, Kim H (2005) Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 21:3175-3181
9. Zhang YW, Eom SY, Kim YD, Song YJ, Yun HY, Park JS, Youn SJ, Kim BS, Kim H, Hein DW (2009) Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans. Int J Cancer 125:139-145
10. Ahn YO (1997) Diet and stomach cancer in Korea. Int J Cancer 10:7-9
11. Kim JH, Shin HS (1997) Effects of main raw material and jeot-kal (fermented fish sauce) on formation of N-nitrosamines during kimchi fermentation. J Food Hyg Safety 12:333-339
12. Seel DJ, Kawabata T, Nakamura M, Ishibashi T, Hamano M, Mashimo M, Shin SH, Sakamoto K, Jhee EC, Watanabe S (1994) N-nitroso compounds in two nitrosated food products in southwest Korea. Food Chem Toxicol 32:1117-1123
13. Ok HE, Kim HJ, Shim WB, Lee H, Bae DH, Chung DH, Chun HS (2007) Natural occurrence of aflatoxin B1 in marketed foods and risk estimates of dietary exposure in Koreans. J Food Prot 70:2824-2828
14. Park JW, Kim EK, Kim YB (2004) Estimation of the daily exposure of Koreans to aflatoxin B1 through food consumption. Food Addit Contam 21:70-75
15. International Agency for Research on Cancer (1993) Aflatoxins. IARC Monogr Eval Carcinog Risks Hum 56:245-395
16. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, Langouet S (1998) Activation and detoxication of aflatoxin B1. Mutat Res 402:121-128
17. Guengerich FP, Johnson WW, Ueng YF, Yamazaki H, Shimada T (1996) Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect 104:557-562
18. Wang JS, Groopman JD (1999) DNA damage by mycotoxins. Mutat Res 424:167-181
19. Bedard LL, Massey TE (2006) Aflatoxin B1-induced DNA damage and its repair. Cancer Lett 241:174-183
20. Tiemersma EW, Omer RE, Bunschoten A, van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E (2001) Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 10:785-791
21. Long XD, Ma Y, Wei YP, Deng ZL (2006) The polymorphisms of GSTM1, GSTT1, HYL12, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 36:48-55
22. Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X et al (2006) Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenet Genomics 16:219-227
23. Kim MK, Lee SS, Ahn YO (1996) Reproducibility and validity of a self-administered semiquantitative food frequency questionnaire among middle-aged men in Seoul. Korean J Commun Nutrit 1:376-394
24. Thorn CF, Aklillu E, Klein TE, Altman RB (2012) PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics 22:73-77
25. Zhou Q, Yu X, Shu C, Cai Y, Gong W, Wang X, Wang DM, Hu S (2011) Analysis of CYP3A4 genetic polymorphisms in Han Chinese. J Hum Genet 56:415-422
26. Liu F, Yuan D, Wei Y, Wang W, Yan L, Wen T, Xu M, Yang J, Li B (2012) Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk. PLoS ONE 7:e43821. doi: 10.1371/journal.pone.0043821
27. Wang X, Chorley BN, Pittman GS, Kleeberger SR, Brothers J 2nd, Liu G, Spira A, Bell DA (2010) Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS ONE 5:e11934. doi: 10.1371/journal.pone.0011934
28. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297
29. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
30. Butler WH, Barnes JM (1966) Carcinoma of the glandular stomach in rats given diets containing aflatoxin. Nature 209:90
31. Larsson P, Tjalve H (1995) Extrahepatic bioactivation of aflatoxin B1 in fetal, infant and adult rats. Chem Biol Interact 94:1-19
32. Ma F, Misumi J, Zhao W, Aoki K, Kudo M (2003) Long-term treatment with sterigmatocystin, a fungus toxin, enhances the development of intestinal metaplasia of gastric mucosa in Helicobacter pylori-infected Mongolian gerbils. Scand J Gastroenterol 38:360-369
33. Misumi J (2004) The mechanisms of gastric cancer development produced by the combination of Helicobacter pylori with sterigmatocystin, a mycotoxin. Nippon Rinsho 62:1377-1386
34. Kusunoki M, Misumi J, Shimada T, Aoki K, Matsuo N, Sumiyoshi H, Yamaguchi T, Yoshioka H (2011) Long-term administration of the fungus toxin, sterigmatocystin, induces intestinal metaplasia and increases the proliferative activity of PCNA, p53, and MDM2 in the gastric mucosa of aged Mongolian gerbils. Environ Health Prev Med 16:224-231
35. Codex Alimentarius Commission (1995) Codex general standard for contaminants and toxins in food and feed, CODEX STAN 193-1995. http://www.codexalimentarius.net/input/download/standards/17/CXS-193e.pdf. Accessed 16 July 2013
36. Wu AH, Yang D, Pike MC (2000) A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 9:1051-1058
37. Li FQ, Yoshizawa T, Kawamura O, Luo XY, Li YW (2001) Aflatoxins and fumonisins in corn from the high-incidence area for human hepatocellular carcinoma in Guangxi, China. J Agric Food Chem 49:4122-4126
38. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10
39. Eaton DA, Gallagher EP, Bammler TK, Kunxe KL (1995) Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetic 5:259-274
40. Boobis AR, Lynch AM, Murray S (1994) CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res 54:89-94
41. Tatemichi M, Nomura S, Ogura T, Sone H, Nagata H, Esumi H (1999) Mutagenic activation of environmental carcinogens by microsomes of gastric mucosa with metaplasia. Cancer Res 59:3893-3898
42. Agudo A, Sala N, Pera G, Capellá G, Berenguer A, García N, Palli D, Boeing H, Del Giudice G, Saieva C, Carneiro F, Berrino F et al (2006) Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15:2427-2434
43. Ikeda S, Sasazuki S, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Ohnami S, Sakamoto H, Yoshida T, Iwasaki M, Tsugane S (2008) Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol 103:1476-1487
44. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T, Tsugane S (2009) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in Japan. Gastric Cancer 12:198-205
45. Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L (2007) Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol 63:537-546
46. Takata K, Saruwatari J, Nakada N, Nakagawa M, Fukuda K, Tanaka F, Takenaka S, Mihara S, Marubayashi T, Nakagawa K (2006) Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy. Eur J Clin Pharmacol 62:23-28
47. Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, Sheu JC, Lin JT (2002) Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 17:338-343
48. Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH (2007) GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev 31:233-236
49. Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K, Shields PG (1996) Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer 77:1654-1661
50. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, Duncan H, Brannigan K et al (1996) Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17:881-884
51. Hong SH, Kim JW, Kim HG, Park IK, Ryoo JW, Lee CH, Sohn YK, Lee JY (2006) Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Public Health 39:135-140